FDA Warns Against Infection Risk From Ophthalmic Drugs Following Meningitis Outbreak
This includes ophthalmic drugs injected or used in conjunction with eye surgery and cardioplegic solutions. Patients should contact their healthcare provider if they experience symptoms of meningitis.
At this time, no cases of infection have been reported in connection with any NECC-produced ophthalmic drug, but the FDA believes the class of products could present similar infection risks.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About